Part 2 Flashcards
A patient has the Lewis phenotype Le(a−b−). An antibody panel reveals the presence of anti-Lea. Another patient with the phenotype Le(a−b+) has a positive antibody screen; however, a panel reveals no conclusive antibody. Should anti-Lea be considered as a possibility for the patient with the Le(a−b+) phenotype?
A. Anti-Lea should be considered as a possible antibody
B. Anti-Lea may be a possible antibody, but further studies are needed
C. Anti-Lea is not a likely antibody because even Leb individuals secrete some Lea
D. Anti-Lea may be found in saliva but not detectable in serum
C. Anti-Lea is not a likely antibody because even Leb individuals secrete some Lea
A technologist is having great difficulty resolving an antibody mixture. One of the antibodies is anti-Lea. This antibody is not clinically significant in this situation, but it needs to be removed to reveal the possible presence of an underlying antibody of clinical significance. What can be done?
A. Perform an enzyme panel
B. Neutralize the serum with saliva
C. Neutralize the serum with hydatid cyst fluid
D. Use DTT (dithiothreitol) to treat the panel cells
B. Neutralize the serum with saliva
What type of blood should be given to an individual who has an anti-Leb that reacts 1+ at the IAT phase?
A. Blood that is negative for the Leb antigen
B. Blood that is negative for both the Lea and Leb antigens
C. Blood that is positive for the Leb antigen
D. Lewis antibodies are not clinically significant, so any type of blood may be given
A. Blood that is negative for the Leb antigen
Which of the following statements is true concerning the MN genotype?
A. Antigens are destroyed using bleach-treated cells
B. Dosage effect may be seen for both M and N antigens
C. Both M and N antigens are impossible to detect because of cross-interference
D. MN is a rare phenotype seldom found in routine antigen typing
B. Dosage effect may be seen for both M and N antigens
Anti-M is sometimes found with reactivity detected at the immediate spin (IS) phase that persists in strength to the IAT phase. What is the main testing problem with a strong anti-M?
A. Anti-M may not allow detection of a clinically significant antibody
B. Compatible blood may not be found for the patient with a strongly reacting anti-M
C. The anti-M cannot be removed from the serum
D. The anti-M may react with the patient’s own cells, causing a positive autocontrol
A. Anti-M may not allow detection of a clinically significant antibody
A patient is suspected of having paroxysmal cold hemoglobinuria (PCH). Which pattern of reactivity is characteristic of the Donath-Landsteiner antibody, which causes this condition?
A. The antibody attaches to RBCs at 4°C and causes hemolysis at 37°C
B. The antibody attaches to RBCs at 37°C and causes agglutination at the IAT phase
C. The antibody attaches to RBCs at 22°C and causes hemolysis at 37°C
D. The antibody attaches to RBCs and causes agglutination at the IAT phase
A. The antibody attaches to RBCs at 4°C and causes hemolysis at 37°C
How can interfering anti-P1 antibody be removed from a mixture of antibodies?
A. Neutralization with saliva
B. Agglutination with human milk
C. Combination with urine
D. Neutralization with hydatid cyst fluid
D. Neutralization with hydatid cyst fluid
Which antibody is frequently seen in patients with warm autoimmune hemolytic anemia?
A. Anti-Jka
B. Anti-e
C. Anti-K
D. Anti-Fyb
B. Anti-e
An antibody shows strong reactions in all test phases. All screen and panel cells are positive. The serum is then tested with a cord cell and the reaction is negative. What antibody is suspected?
A. Anti-I
B. Anti-i
C. Anti-H
D. Anti-p
A. Anti-I
Which group of antibodies is commonly found as cold agglutinins?
A. Anti-K, anti-k, anti-Jsb
B. Anti-D, anti-e, anti-C
C. Anti-M, anti-N
D. Anti-Fya, anti-Fyb
C. Anti-M, anti-N
Which of the following antibodies characteristically gives a refractile mixed-field appearance?
A. Anti-K
B. Anti-Dia
C. Anti-Sda
D. Anti-s
C. Anti-Sda
What does the 3+3 rule ascertain?
A. An antibody is ruled in
B. An antibody is ruled out
C. 95% confidence that the correct antibody has been identified
D. 95% confidence that the correct antibody has not been identified
C. 95% confidence that the correct antibody has been identified
The k (Cellano) antigen is a high-frequency antigen and is found on most red cells. How often would one expect to find the corresponding antibody?
A. Often, because it is a high frequency antibody
B. Rarely, because most individuals have the antigen and therefore would not develop the antibody
C. It depends upon the population, because certain racial and ethnic groups show a higher frequency of anti-k
D. Impossible to determine without consulting regional blood group antigen charts
B. Rarely, because most individuals have the antigen and therefore would not develop the antibody
Which procedure would help to distinguish between an anti-e and anti-Fya in an antibody mixture?
A. Lower the pH of test serum
B. Run an enzyme panel
C. Use a thiol reagent
D. Run a LISS panel
B. Run an enzyme panel
Which characteristics are true of all three of the following antibodies: anti-Fya, anti-Jka, and anti-K?
A. Detected at the IAT phase; may cause hemolytic disease of the newborn and hemolytic transfusion Reactions
B. Not detected with enzyme-treated cells
C. Requires the IAT technique for detection; usually not associated with HDN
D. Enhanced reactivity with enzyme-treated cells; may cause severe hemolytic transfusion reactions
A. Detected at the IAT phase; may cause hemolytic disease of the newborn and hemolytic transfusion Reactions
A patient is admitted to the hospital. Medical records indicate that the patient has a history of anti-Jka. When you performed the type and screen, the type was O positive and screen was negative. You should:
A. Crossmatch using units negative for Jka antigen
B. Crossmatch random units, since the antibody is not demonstrating
C. Request a new sample
D. Repeat the screen with enzyme-treated screening cells
A. Crossmatch using units negative for Jka antigen
A technologist performs an antibody study and finds 1+ and weak positive reactions for several of the panel cells. The reactions do not fit a pattern. Several selected panels and a patient phenotype do not reveal any additional information. The serum is diluted and retested, but the same reactions persist. What type of antibody may be causing these results?
A. Antibody to a high-frequency antigen
B. Antibody to a low-frequency antigen
C. High titer low avidity (HTLA)
D. Anti-HLA
C. High titer low avidity (HTLA)
An antibody is detected in a pregnant woman and is suspected of being the cause of fetal distress. The antibody reacts at the IAT phase but does not react with DTT-treated cells. This antibody causes in vitro hemolysis. What is the most likely antibody specificity?
A. Anti-Lea
B. Anti-Lua
C. Anti-Lub
D. Anti-Xga
C. Anti-Lub
What sample is best for detecting complement-dependent antibodies?
A. Plasma stored at 4°C for no longer than 24 hours
B. Serum stored at 4°C for no longer than 48 hours
C. Either serum or plasma stored at 20°C-24°C no longer than 6 hours
D. Serum heated at 56°C for 30 minutes
B. Serum stored at 4°C for no longer than 48 hours
Which antibody would not be detected by group O screening cells?
A. Anti-N
B. Anti-A1
C. Anti-Dia
D. Anti-k
B. Anti-A1
Refer to Panel 1. Which antibody is most likely implicated?
A. Anti-Fyb
B. Anti-Jkb
C. Anti-e
D. Anti-c and anti-K
Link to Panels (https://docs.google.com/document/d/1PTPii_JLOi-ow0MWtPPDn4NMQB-AGkN_mKYVj_A2xmg/edit?usp=sharing)
B. Anti-Jkb
Refer to Panel 2. Which antibody specificity is most likely present?
A. Anti-S and anti-E
B. Anti-E and anti-K
C. Anti-Lea and anti-Fyb
D. Anti-C and anti-K
Link to Panels (https://docs.google.com/document/d/1PTPii_JLOi-ow0MWtPPDn4NMQB-AGkN_mKYVj_A2xmg/edit?usp=sharing)
D. Anti-C and anti-K